Related Experiment Video
Updated: Jun 20, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?
Natalie Grizenko1, Michael Paci, Ridha Joober
1McGill University. grinat@douglas.mcgill.ca
Attention-Deficit/Hyperactivity Disorder (ADHD) subtypes, combined/hyperactive (ADHD/CH) and inattentive (ADHD/I), show distinct patterns in comorbidity, genetics, and prenatal factors. These differences suggest ADHD/CH and ADHD/I may represent separate conditions.
Area of Science:
- Child and Adolescent Psychiatry
- Neurodevelopmental Disorders
- Genetics
Background:
- Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder.
- ADHD presents with distinct subtypes, primarily the combined/hyperactive (ADHD/CH) and inattentive (ADHD/I) forms.
- Understanding subtype differences is crucial for targeted interventions and etiological research.
Purpose of the Study:
- To compare the ADHD combined/hyperactive (ADHD/CH) subtype with the ADHD inattentive (ADHD/I) subtype.
- Investigate differences in comorbidity, treatment response, and potential etiological factors.
- Explore genetic predispositions and prenatal influences differentiating the subtypes.
Main Methods:
- A double-blind, placebo-controlled trial involving 371 children aged 6-12 diagnosed with ADHD.
- Assessment of comorbidities, treatment response to methylphenidate, and prenatal stress.
- Genotyping of DAT, DRD4, and 5-HTT genes; maternal reports on smoking/alcohol use and birth weight.
Main Results:
- ADHD/CH children exhibited higher rates of conduct disorder and a better treatment response.
- Increased exposure to moderate prenatal stress was noted in mothers of ADHD/CH children.
- A higher frequency of the L/L genotype for the 5-HTT-linked polymorphic region was observed in ADHD/CH.
Conclusions:
- Significant differences in comorbidity, treatment response, and genetic factors were identified between ADHD/CH and ADHD/I subtypes.
- These findings suggest that ADHD/CH and ADHD/I may represent distinct etiological entities.
- Further research is warranted to elucidate the separate pathways underlying these ADHD subtypes.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Personality Disorders: Dependent and Obsessive-Compulsive
Dependent Personality Disorder
Dependent personality disorder is characterized by an excessive reliance on others to manage various aspects of life. Individuals with this disorder often struggle with...
High-Level and Low-Level Awareness
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...

